Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 6/20 | 0.63 |
| ▸ | GHSR | Q92847 | 6/20 | 0.60 |
| ▸ | ECE1 | P42892 | 5/20 | 0.58 |
| ▸ | IL1RN | P18510 | 5/20 | 0.58 |
| ▸ | ERAP1 | Q9NZ08 | 4/20 | 0.58 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.56 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.56 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.56 |
| ▸ | ACE | P12821 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31720495 | 0.97 | ERAP2 (0.63) | ERAP2GHSRECE1IL1RNERAP1 | |
| SCHEMBL31004373 | 0.96 | ERAP2 (0.61) | ERAP2GHSRECE1IL1RNERAP1 | |
| SCHEMBL30788017 | 0.94 | ERAP2 (0.64) | ERAP2GHSRECE1IL1RNERAP1 | |
| SCHEMBL29531497 | 0.94 | ERAP2 (0.61) | ERAP2GHSRECE1IL1RNERAP1 | |
| SCHEMBL31004384 | 0.94 | ERAP2 (0.61) | ERAP2GHSRECE1IL1RNERAP1 | |
| SCHEMBL30929763 | 0.94 | ERAP2 (0.58) | ERAP2GHSRECE1IL1RNERAP1 | |
| SCHEMBL31720527 | 0.93 | ERAP2 (0.63) | ERAP2GHSRECE1IL1RNERAP1 | |
| SCHEMBL30465909 | 0.93 | ERAP2 (0.70) | ERAP2GHSRECE1IL1RNERAP1 | |
| SCHEMBL29691762 | 0.93 | ERAP2 (0.70) | ERAP2GHSRECE1IL1RNERAP1 | |
| SCHEMBL30416193 | 0.92 | ECE1 (0.64) | ERAP2GHSRECE1IL1RNERAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| WO-2024240173-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2024-11-28 | — | — | WO | claimed |